Experts
Opyl (ASX: OPL) are a Melbourne based company with client service and development teams in both Australia and the US.
Opyl provides biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Stockhead TV
How can artificial intelligence revolutionise healthcare?
Tech
Opyl snares ex-Cochlear executive as medtech’s platforms approach launch
Health & Biotech
AI in healthcare: 3 ASX small caps discuss their recipe for success
Experts
ScoPo’s health powerplays: Pot stocks get a boost
News
Rise and Shine: What you need to know before the ASX opens
Experts
Scopo’s Health Powerplays: Show me the (grant) money
News
Rise and Shine: What you need to know before the ASX opens
Tech
Opyl clinical trial prediction tool completes COVID-19 proof-of-concept
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s marching ahead this morning?
News
10 at 10: These ASX stocks are ballooning upwards this morning
Tech
Turnaround story: Opyl’s new look
Tech
Opyl’s artificial intelligence will change clinical trials forever
Health & Biotech
Opyl is eyeing a 30pc revenue hike in 2021
Experts
Scopo’s health powerplays: Markets are getting back to normal
News
Rise and Shine: What you need to know before the ASX opens
News